Evidence-based therapy of acute renal failure.
Lameire
N
N
Department of Medicine, University Hospital, Gent.
Vanholder
R
R
Van Biesen
W
W
De Vriese
A
A
Dhondt
A
A
Veys
N
N
Hoeben
H
H
Colardyn
F
F
D058186:Acute Kidney Injury / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use; D001672:Biocompatible Materials; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D008353:Mannitol / Q000627:therapeutic use; D008567:Membranes, Artificial; D010446:Peptide Fragments / Q000627:therapeutic use; D012076:Renal Agents / Q000627:therapeutic use; D012079:Renal Circulation / Q000187:drug effects / Q000502:physiology; D006435:Renal Dialysis / Q000295:instrumentation; D017582:Renal Replacement Therapy
D001672:Biocompatible Materials; D002121:Calcium Channel Blockers; D004232:Diuretics; D004234:Diuretics, Osmotic; D006133:Growth Substances; D008567:Membranes, Artificial; D010446:Peptide Fragments; D012076:Renal Agents; D008353:Mannitol; C056452:Ularitide; D009320:Atrial Natriuretic Factor; D004298:Dopamine